Exenatide Microspheres

Brand name: Bydureon Bcise

Rank #235 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$56.6M

Total Cost

Share:

48,670

Total Claims

$56.6M

Total Cost

2,660

Prescribers

$1,162

Cost per Claim

1,443

Beneficiaries

67,010

30-Day Fills

$21K

Avg Cost/Provider

18

Avg Claims/Provider

Share of Medicare Part D Spending

0.02%

of total Medicare Part D spending

$56.6M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $56.6M total

🔎 Data Overview

💰

At $1,162 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

👤

Average cost of $39,208 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Exenatide Microspheres

#ProviderSpecialtyLocationClaimsCost
1Kristopher KochInternal MedicineSan Antonio, TX125$309K
2Hernan BaquerizoEndocrinologyMiami, FL225$276K
3Patricia LaneFamily PracticePleasanton, TX127$240K
4Enrique GriegoFamily PracticeMcallen, TX143$226K
5Luis BielerInternal MedicineSan Antonio, TX85$205K
6John FritzFamily PracticeJersey City, NJ191$191K
7Avegiyel DunnFamily PracticePortland, TX81$187K
8Gerald MiceliEndocrinologyOrmond Beach, FL259$180K
9Gregory MccarrollInternal MedicineSan Antonio, TX102$165K
10Navinder JassilEndocrinologyMoorestown, NJ90$159K
11Eleanora SaenzInternal MedicineSan Antonio, TX80$154K
12Shashi MittalFamily PracticeSan Antonio, TX58$149K
13Daniel SoEndocrinologyArlington Heights, IL72$145K
14Gurjeev RattanEndocrinologyNorth Babylon, NY67$136K
15Christopher ChappelFamily PracticeKissimmee, FL188$134K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
232Lumateperone Tosylate (Caplyta)$57.4M35,791
233Everolimus (Everolimus)$57.0M8,962
234Allopurinol (Allopurinol)$56.9M3,852,206
235Exenatide Microspheres (Bydureon Bcise)$56.6M48,670
236Valsartan (Valsartan)$56.4M1,481,937
237Benralizumab (Fasenra Pen)$54.8M9,334
238Netarsudil Mesylat/Latanoprost (Rocklatan)$54.7M103,171

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology